Skip to main content
Top
Published in: Abdominal Radiology 12/2017

01-12-2017

A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis

Authors: Cherry Kim, Jae Ho Byun, Seung-Mo Hong, Soyeon An, Jin Hee Kim, Seung Soo Lee, Hyoung Jung Kim

Published in: Abdominal Radiology | Issue 12/2017

Login to get access

Abstract

Purpose

To compare CT findings and survival between patients with pancreatic neuroendocrine tumors (pNETs) with and without fibrosis.

Methods

Forty-five pNET patients with intratumoral fibrosis (group A) were matched for age, gender, and tumor size and grade with 45 pNET patients without (group B), and CT images were retrospectively reviewed. Hounsfield units (HUs) of tumors in unenhanced, arterial and portal phases, HU ratio (tumor to normal parenchyma) in each phase, enhancement patterns, visible enhancement pattern changes, and survival were compared.

Results

Group A showed progressive enhancement patterns, while group B showed early enhancement and wash-out patterns (p < 0.05). HUs of tumors and HU ratio in the unenhanced phase were significantly higher in group A than group B (p ≤ 0.024), whereas those in the arterial phase were significantly lower in group A than group B (p ≤ 0.003). Peripheral to full or peripheral to peripheral enhancement change was more frequent in group A, while full to full enhancement change was more frequent in group B (p < 0.05). Group A showed significantly lower overall survival than group B (p = 0.029).

Conclusions

pNETs with fibrosis showed a progressive enhancement pattern and worse overall survival than pNETs without, which showed an early enhancement and wash-out pattern.
Literature
1.
go back to reference Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system, 4th edn. Lyon: IARC Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system, 4th edn. Lyon: IARC
3.
8.
go back to reference Kim DW, Kim HJ, Kim KW, et al. (2015) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 25(5):1375–1383. doi:10.1007/s00330-014-3532-z CrossRefPubMed Kim DW, Kim HJ, Kim KW, et al. (2015) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 25(5):1375–1383. doi:10.​1007/​s00330-014-3532-z CrossRefPubMed
9.
go back to reference Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S (2015) Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: spectrum of imaging findings and pathological grading. Eur J Radiol 84(11):2103–2109. doi:10.1016/j.ejrad.2015.08.014 CrossRefPubMed Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S (2015) Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: spectrum of imaging findings and pathological grading. Eur J Radiol 84(11):2103–2109. doi:10.​1016/​j.​ejrad.​2015.​08.​014 CrossRefPubMed
10.
go back to reference Rodallec M, Vilgrain V, Couvelard A, et al. (2006) Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 6(1–2):77–85. doi:10.1159/000090026 CrossRefPubMed Rodallec M, Vilgrain V, Couvelard A, et al. (2006) Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 6(1–2):77–85. doi:10.​1159/​000090026 CrossRefPubMed
11.
go back to reference d’Assignies G, Couvelard A, Bahrami S, et al. (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250(2):407–416. doi:10.1148/radiol.2501080291 CrossRefPubMed d’Assignies G, Couvelard A, Bahrami S, et al. (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250(2):407–416. doi:10.​1148/​radiol.​2501080291 CrossRefPubMed
12.
go back to reference Kim DW, Kim HJ, Kim KW, et al. (2016) Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients. Eur Radiol 26(5):1320–1329. doi:10.1007/s00330-015-3943-5 CrossRefPubMed Kim DW, Kim HJ, Kim KW, et al. (2016) Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients. Eur Radiol 26(5):1320–1329. doi:10.​1007/​s00330-015-3943-5 CrossRefPubMed
13.
go back to reference Hoshino A, Aimoto T, Suzuki H, et al. (2014) A case of nonfunctioning pancreatic endocrine tumor with atypical imaging findings due to prominent fibrosis of the tumor stroma. J Nippon Med School 81(5):346–352CrossRef Hoshino A, Aimoto T, Suzuki H, et al. (2014) A case of nonfunctioning pancreatic endocrine tumor with atypical imaging findings due to prominent fibrosis of the tumor stroma. J Nippon Med School 81(5):346–352CrossRef
16.
go back to reference Couvelard A, O’Toole D, Turley H, et al. (2005) Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 92(1):94–101. doi:10.1038/sj.bjc.6602245 CrossRefPubMed Couvelard A, O’Toole D, Turley H, et al. (2005) Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 92(1):94–101. doi:10.​1038/​sj.​bjc.​6602245 CrossRefPubMed
17.
go back to reference Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. (2007) Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res 13(1):187–196. doi:10.1158/1078-0432.CCR-06-1408 CrossRefPubMed Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. (2007) Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res 13(1):187–196. doi:10.​1158/​1078-0432.​CCR-06-1408 CrossRefPubMed
18.
go back to reference Marion-Audibert AM, Barel C, Gouysse G, et al. (2003) Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 125(4):1094–1104CrossRefPubMed Marion-Audibert AM, Barel C, Gouysse G, et al. (2003) Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 125(4):1094–1104CrossRefPubMed
Metadata
Title
A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis
Authors
Cherry Kim
Jae Ho Byun
Seung-Mo Hong
Soyeon An
Jin Hee Kim
Seung Soo Lee
Hyoung Jung Kim
Publication date
01-12-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1212-6

Other articles of this Issue 12/2017

Abdominal Radiology 12/2017 Go to the issue

Classics in Abdominal Imaging

Iliac “horns”